{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:23:44Z","timestamp":1778750624084,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.humimm.2023.110738","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T15:10:53Z","timestamp":1701357053000},"page":"110738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The causal relationship between ankylosing spondylitis and the risk of ovarian cancer"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8294-8588","authenticated-orcid":false,"given":"Xiao","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongzheng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congcong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengxiang","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.humimm.2023.110738_b0005","first-page":"335","article-title":"Metabolic risk factors of ovarian cancer: a review","volume":"26","author":"Khanlarkhani","year":"2022","journal-title":"JBRA Assist. Reprod."},{"issue":"10177","key":"10.1016\/j.humimm.2023.110738_b0010","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet (London, England)."},{"issue":"2","key":"10.1016\/j.humimm.2023.110738_b0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.soncn.2019.02.001","article-title":"Ovarian Cancer: An Integrated Review","volume":"35","author":"Stewart","year":"2019","journal-title":"Semin. Oncol. Nurs."},{"issue":"4","key":"10.1016\/j.humimm.2023.110738_b0020","first-page":"280","article-title":"Epithelial ovarian cancer: Evolution of management in the era of precision medicine","volume":"69","author":"Lheureux","year":"2019","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.humimm.2023.110738_b0025","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/S1470-2045(18)30786-1","article-title":"Exploring and comparing adverse events between PARP inhibitors","volume":"20","author":"LaFargue","year":"2019","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.humimm.2023.110738_b0030","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.hoc.2018.07.003","article-title":"Early Detection of Ovarian Cancer","volume":"32","author":"Elias","year":"2018","journal-title":"Hematology\/Oncol. Clin. North America."},{"key":"10.1016\/j.humimm.2023.110738_b0035","first-page":"7","article-title":"Recent advances in ankylosing spondylitis: understanding the disease and management","author":"Garcia-Montoya","year":"2018","journal-title":"F1000Research"},{"issue":"5","key":"10.1016\/j.humimm.2023.110738_b0040","first-page":"967","article-title":"Effects of ankylosing spondylitis and non-radiographic axial spondyloarthropathy on female sexual functions","volume":"40","author":"G\u00f6z\u00fck\u00fc\u00e7\u00fck","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"issue":"5","key":"10.1016\/j.humimm.2023.110738_b0045","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cac2.12283","article-title":"The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large-scale cohort study in China","volume":"42","author":"Zhou","year":"2022","journal-title":"Cancer Commun. (London, England)."},{"key":"10.1016\/j.humimm.2023.110738_b0050","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3389\/fimmu.2019.01232","article-title":"Editorial: Ankylosing Spondylitis and Related Immune-Mediated Disorders","volume":"10","author":"Fiorillo","year":"2019","journal-title":"Front. Immunol."},{"issue":"16","key":"10.1016\/j.humimm.2023.110738_b0055","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.humimm.2023.110738_b0060","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hep.32534","article-title":"Relationship between NAFLD and coronary artery disease: A Mendelian randomization study","volume":"77","author":"Ren","year":"2023","journal-title":"Hepatology (Baltimore, Md)."},{"issue":"2","key":"10.1016\/j.humimm.2023.110738_b0065","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/ATVBAHA.119.313055","article-title":"Causal Associations Between Serum Bilirubin Levels and Decreased Stroke Risk: A Two-Sample Mendelian Randomization Study","volume":"40","author":"Choi","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.humimm.2023.110738_b0070","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03196-2020","article-title":"Lung function and cardiovascular disease: a two-sample Mendelian randomisation study","volume":"58","author":"Higbee","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"7708","key":"10.1016\/j.humimm.2023.110738_b0075","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","article-title":"Genomic atlas of the human plasma proteome","volume":"558","author":"Sun","year":"2018","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.humimm.2023.110738_b0080","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s00198-023-06807-6","article-title":"Causal relationship between type 2 diabetes mellitus and bone mineral density: a Mendelian randomization study in an East Asian population","volume":"34","author":"Huang","year":"2023","journal-title":"Osteoporosis Int. : J. Established Result Cooperat. European Found. Osteoporosis Natl. Osteoporosis Found. USA"},{"issue":"1","key":"10.1016\/j.humimm.2023.110738_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12010347","article-title":"The causal effect of reproductive factors on breast cancer: a two-sample mendelian randomization study","volume":"12","author":"Jia","year":"2023","journal-title":"J. Clin. Med."},{"issue":"16","key":"10.1016\/j.humimm.2023.110738_b0090","first-page":"4521","article-title":"Metasubtract: an R-package to analytically produce leave-one-out meta-analysis GWAS summary statistics","volume":"36","author":"Nolte","year":"2020","journal-title":"Bioinformatics (Oxford, England)."},{"key":"10.1016\/j.humimm.2023.110738_b0095","doi-asserted-by":"crossref","unstructured":"D.K. Armstrong, R.D. Alvarez, J.N. Bakkum-Gamez, L. Barroilhet, K. Behbakht, A. Berchuck, et al., Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology, J. Natl. Comprehensive Cancer Network : JNCCN. 2021;19(2):191-226.","DOI":"10.6004\/jnccn.2021.0007"},{"issue":"6","key":"10.1016\/j.humimm.2023.110738_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/cells9061402","article-title":"Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer","volume":"9","author":"Mu\u00f1oz-Galv\u00e1n","year":"2020","journal-title":"Cells."},{"issue":"4","key":"10.1016\/j.humimm.2023.110738_b0105","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00404-020-05458-w","article-title":"Use of oral contraceptives in BRCA mutation carriers and risk for ovarian and breast cancer: a systematic review","volume":"301","author":"Huber","year":"2020","journal-title":"Arch. Gynecol. Obstetrics."},{"issue":"4","key":"10.1016\/j.humimm.2023.110738_b0110","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10238-018-0508-3","article-title":"TNF-R2 in tumor microenvironment as prognostic factor in epithelial ovarian cancer","volume":"18","author":"Nomelini","year":"2018","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.humimm.2023.110738_b0115","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.biopha.2018.10.137","article-title":"Ankylosing spondylitis and mesenchymal stromal\/stem cell therapy: a new therapeutic approach","volume":"109","author":"Abdolmohammadi","year":"2019","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.humimm.2023.110738_b0120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nyas.13933","article-title":"Targeting tumor necrosis factor receptors in ankylosing spondylitis","volume":"1442","author":"Lata","year":"2019","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"5","key":"10.1016\/j.humimm.2023.110738_b0125","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s10067-020-05519-0","article-title":"Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis-time to reconsider treatment guidelines? A case series and review of literature","volume":"40","author":"Rocha","year":"2021","journal-title":"Clin. Rheumatol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885923003725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885923003725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:58:59Z","timestamp":1759319939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885923003725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0198885923003725"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2023.110738","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The causal relationship between ankylosing spondylitis and the risk of ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2023.110738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110738"}}